iSpecimen Inc. Investment Income, Interest
iSpecimen Inc. (ISPC) reported Investment Income, Interest of $270 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-14
- iSpecimen Inc. investment income, interest for the quarter ending 2026-06-30 was $270.00, a 32.16% decline year-over-year.
- iSpecimen Inc. investment income, interest for the quarter ending 2026-03-31 was $291.00, a 89.56% decline year-over-year.
- iSpecimen Inc. investment income, interest for the quarter ending 2025-12-31 was $271.00, a 91.63% decline year-over-year.
- iSpecimen Inc. investment income, interest for the quarter ending 2025-09-30 was $291.00, a 76.44% decline year-over-year.
- iSpecimen Inc. investment income, interest for fiscal 2025 was $3.75K, a 91.51% decline from fiscal 2024.
- iSpecimen Inc. investment income, interest for fiscal 2024 was $44.13K.
- iSpecimen Inc. investment income, interest for fiscal 2021 was $11.40K, a 2508.01% increase from fiscal 2020.
- iSpecimen Inc. investment income, interest for fiscal 2020 was $437.00.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $270.00 10-Q · filed 2026-08-14 | $561.00 10-Q · filed 2026-08-14 | $832.00 derived: sum of 3 quarters · filed 2026-08-14 | $1.12K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $291.00 10-Q · filed 2026-05-18 | $562.00 derived: sum of 2 quarters · filed 2026-05-18 | $853.00 derived: sum of 3 quarters · filed 2026-05-18 | $1.25K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $271.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $562.00 derived: sum of 2 quarters · filed 2026-04-01 | $960.00 derived: sum of 3 quarters · filed 2026-08-14 | $3.75K 10-K · filed 2026-04-01 |
| 2025-09-30 | $291.00 10-Q · filed 2025-11-17 | $689.00 derived: sum of 2 quarters · filed 2026-08-14 | $3.48K 10-Q · filed 2025-11-17 | $6.71K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $398.00 10-Q · filed 2026-08-14 | $3.19K 10-Q · filed 2026-08-14 | $6.42K derived: sum of 3 quarters · filed 2026-08-14 | $7.66K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.79K 10-Q · filed 2026-05-18 | $6.03K derived: sum of 2 quarters · filed 2026-05-18 | $7.26K derived: sum of 3 quarters · filed 2026-05-18 | $16.42K derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | $3.24K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $4.47K derived: sum of 2 quarters · filed 2026-04-01 | $13.63K derived: sum of 3 quarters · filed 2026-04-01 | $44.13K 10-K · filed 2026-04-01 |
| 2024-09-30 | $1.24K 10-Q · filed 2025-11-17 | $10.40K derived: sum of 2 quarters · filed 2025-11-17 | $40.90K 10-Q · filed 2025-11-17 | |
| 2024-06-30 | $9.16K 10-Q · filed 2025-08-14 | $39.66K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $30.50K 10-Q · filed 2025-05-19 | |||
| 2022-06-30 | $13.88K 10-Q · filed 2022-08-04 | $26.54K 10-Q · filed 2022-08-04 | ||
| 2022-03-31 | $12.65K 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $11.40K 10-K · filed 2022-03-22 | |||
| 2021-06-30 | $172.00 10-Q · filed 2022-08-04 | $219.00 derived: sum of 2 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $47.00 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $437.00 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |